Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis (ELEVATE UC 52)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03945188
Recruitment Status : Active, not recruiting
First Posted : May 10, 2019
Last Update Posted : March 26, 2021
Sponsor:
Information provided by (Responsible Party):
Arena Pharmaceuticals

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : January 2022
Estimated Study Completion Date : January 2022